Intensive Treatment Preserves Beta Cells
Research news from the American Diabetes Association 72nd Scientific Sessions
June 8–12, 2012 | Philadelphia, Pennsylvania
Intensive diabetes treatment at diagnosis can preserve beta cell function (the body's production of insulin) in people with type 2, a study found. After three months of insulin injections and metformin, participants were randomly assigned to either continue the treatment or to switch to the oral medications metformin, glyburide, and pioglitazone (Actos). All participants' beta cells kept producing insulin—even 3 1/2 years later. (Loss of beta cell functioning typically leads diabetes to become more severe in people with type 2.) The researchers say the study is proof that people with type 2 diabetes should begin one of these intensive medication therapies immediately, along with an eating plan and exercise.
Source: Diabetes Care, July 2012